UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):
May 8, 2009


CHEMED CORPORATION
(Exact name of registrant as specified in its charter)

Delaware

1-8351

31-0791746

(State or other

jurisdiction of

incorporation)

(Commission File Number)

(I.R.S. Employer

Identification

Number)

2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices)           (Zip Code)


Registrant’s telephone number, including area code:
(513) 762-6900


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Page 1 of 2

Item 8.01     Other Events

On May 8, 2009 the Company’s VITAS subsidiary received an administrative subpoena from the U.S. Department of Justice requesting VITAS deliver to the Office of Inspector General documents, patient records, and policy and procedure manuals concerning hospice services provided by VITAS for the period January 1, 2003 to the present. Based on the early stage of this investigation and the limited information that we have at this time, the Company cannot predict the outcome of this investigation, the U.S. Attorney’s views of the issues being investigated, any actions that the U.S. Attorney may take or the impact, if any, that the investigation may have on our business, results of operations, liquidity or capital resources. We believe that we are in material compliance with the rules and regulations applicable to the Medicare and Medicaid hospice program.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

CHEMED CORPORATION

 

 

Dated:

May 14, 2009

By:

  /s/  Arthur V. Tucker, Jr.

Arthur V. Tucker, Jr.

Vice President and Controller

Page 2 of 2